Key result
Balloon mitral valvotomy in pregnant women with severe rheumatic mitral stenosis significantly increased mean mitral valve area from 0.93 cm2 to 1.75 cm2 (p<0.0001) with a 95.9% procedural success rate.
Why the study?
Does balloon mitral valvotomy improve hemodynamics and maternal/fetal outcomes in pregnant women with rheumatic mitral stenosis?
Population
49 pregnant women with rheumatic mitral stenosis in India, mean age 25.7 ± 3.1 years, mean gestational age…
Design
Case_series
Follow-up
Up to delivery
Authors
Loading...
BMV may be feasible in pregnant women with severe rheumatic MS; leaves open confirmation of maternal-fetal outcome benefits in controlled studies.
Observational (n=49)
Does balloon mitral valvotomy improve hemodynamics and maternal/fetal outcomes in pregnant women with rheumatic mitral stenosis?
Absolute Event Rate: 1.75% vs 0.93%
p-value: p=<0.0001
Balloon mitral valvotomy is a safe and effective treatment for severe rheumatic mitral stenosis during pregnancy, providing significant hemodynamic improvement and favorable obstetric outcomes.
Vinayakumar et al. (2016) conducted an observational in Rheumatic mitral stenosis in pregnancy (n=49). Balloon mitral valvotomy (BMV) vs. Pre-procedure baseline was evaluated on Mean two-dimensional mitral valve area (cm2) (p=<0.0001). Balloon mitral valvotomy in pregnant women with severe rheumatic mitral stenosis significantly increased mean mitral valve area from 0.93 cm2 to 1.75 cm2 (p<0.0001) with a 95.9% procedural success rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: